{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T11:35:19Z","timestamp":1786707319509,"version":"build-2736575974"},"reference-count":95,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Physiol Biochem"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s13105-026-01215-w","type":"journal-article","created":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T09:17:12Z","timestamp":1786699032000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The LKB1-AMPK pathway in NAFLD: molecular mechanisms and therapeutic implications"],"prefix":"10.1007","volume":"82","author":[{"given":"Pouya","family":"Goleij","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Amin Khazeei","family":"Tabari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yousef","family":"Naser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rayan","family":"Alataa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed Ali Mohammed","family":"Osman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aryan","family":"Rezaee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Aschner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed Rabie Dahab","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moaad Abou","family":"Safrah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haroon","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,14]]},"reference":[{"issue":"9","key":"1215_CR1","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1093\/cvr\/cvad095","volume":"119","author":"C Grander","year":"2023","unstructured":"Grander C, Grabherr F, Tilg H (2023) Non-alcoholic fatty liver disease: pathophysiological concepts and treatment options. Cardiovascular Res 119(9):1787\u20131798","journal-title":"Cardiovascular Res"},{"issue":"3","key":"1215_CR2","doi-asserted-by":"publisher","first-page":"194","DOI":"10.32074\/1591-951X-242","volume":"113","author":"I Cataldo","year":"2021","unstructured":"Cataldo I, Sarcognato S, Sacchi D, Cacciatore M, Baciorri F, Mangia A et al (2021) Pathology of non-alcoholic fatty liver disease. Pathologica 113(3):194","journal-title":"Pathologica"},{"issue":"22","key":"1215_CR3","doi-asserted-by":"publisher","first-page":"5458","DOI":"10.3390\/cancers15225458","volume":"15","author":"BM Motta","year":"2023","unstructured":"Motta BM, Masarone M, Torre P, Persico M (2023) From non-alcoholic steatohepatitis (NASH) to hepatocellular carcinoma (HCC): epidemiology, incidence, predictions, risk factors, and prevention. Cancers 15(22):5458","journal-title":"Cancers"},{"issue":"6","key":"1215_CR4","doi-asserted-by":"publisher","first-page":"e70132","DOI":"10.1002\/edm2.70132","volume":"8","author":"DM Miller","year":"2025","unstructured":"Miller DM, McCauley KF, Dunham-Snary KJ (2025) Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Mechanisms, Clinical Implications and Therapeutic Advances. Endocrinol Diabetes Metab 8(6):e70132","journal-title":"Endocrinol Diabetes Metab"},{"issue":"6","key":"1215_CR5","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","volume":"78","author":"ME Rinella","year":"2023","unstructured":"Rinella ME, Lazarus JV, Ratziu V, Francque SM, Sanyal AJ, Kanwal F et al (2023) A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Hepatology 78(6):1966\u20131986","journal-title":"Hepatology"},{"issue":"1","key":"1215_CR6","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/s41598-018-36460-7","volume":"9","author":"Y Pang","year":"2019","unstructured":"Pang Y, Kartsonaki C, Turnbull I, Guo Y, Chen Y, Clarke R et al (2019) Adiposity in relation to risks of fatty liver, cirrhosis and liver cancer: a prospective study of 0.5 million Chinese adults. Sci Rep 9(1):785","journal-title":"Sci Rep"},{"issue":"10290","key":"1215_CR7","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","volume":"397","author":"EE Powell","year":"2021","unstructured":"Powell EE, Wong VW-S, Rinella M (2021) Non-alcoholic fatty liver disease. Lancet 397(10290):2212\u20132224","journal-title":"Lancet"},{"issue":"6","key":"1215_CR8","doi-asserted-by":"publisher","first-page":"e0325961","DOI":"10.1371\/journal.pone.0325961","volume":"20","author":"S Huang","year":"2025","unstructured":"Huang S, Hu W, Fang T (2025) The global impact of non-alcoholic fatty liver disease (including cirrhosis) in the elderly from 1990 to 2021 and future projections of disease burden. PLoS ONE 20(6):e0325961","journal-title":"PLoS ONE"},{"issue":"4","key":"1215_CR9","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.jhep.2019.06.021","volume":"71","author":"ZM Younossi","year":"2019","unstructured":"Younossi ZM, Golabi P, de Avila L, Paik JM, Srishord M, Fukui N et al (2019) The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: a systematic review and meta-analysis. J Hepatol 71(4):793\u2013801","journal-title":"J Hepatol"},{"issue":"17","key":"1215_CR10","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1056\/NEJMoa2029349","volume":"385","author":"AJ Sanyal","year":"2021","unstructured":"Sanyal AJ, Van Natta ML, Clark J, Neuschwander-Tetri BA, Diehl A, Dasarathy S et al (2021) Prospective study of outcomes in adults with nonalcoholic fatty liver disease. N Engl J Med 385(17):1559\u20131569","journal-title":"N Engl J Med"},{"issue":"4","key":"1215_CR11","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1038\/sj.emboj.7600110","volume":"23","author":"JM Lizcano","year":"2004","unstructured":"Lizcano JM, G\u00f6ransson O, Toth R, Deak M, Morrice NA, Boudeau J et al (2004) LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK\/PAR-1. Embo j 23(4):833\u2013843","journal-title":"Embo j"},{"key":"1215_CR12","doi-asserted-by":"publisher","first-page":"8730816","DOI":"10.1155\/2019\/8730816","volume":"2019","author":"F Ciccarese","year":"2019","unstructured":"Ciccarese F, Zulato E, Indraccolo S (2019) LKB1\/AMPK Pathway and Drug Response in Cancer: A Therapeutic Perspective. Oxid Med Cell Longev 2019:8730816","journal-title":"Oxid Med Cell Longev"},{"issue":"1","key":"1215_CR13","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1186\/s12964-024-01689-5","volume":"22","author":"CB Trelford","year":"2024","unstructured":"Trelford CB, Shepherd TG (2024) LKB1 biology: assessing the therapeutic relevancy of LKB1 inhibitors. Cell Communication Signal 22(1):310","journal-title":"Cell Communication Signal"},{"issue":"34","key":"1215_CR14","doi-asserted-by":"publisher","first-page":"12279","DOI":"10.1074\/jbc.REV120.011356","volume":"295","author":"P Zhao","year":"2020","unstructured":"Zhao P, Saltiel AR (2020) From overnutrition to liver injury: AMP-activated protein kinase in nonalcoholic fatty liver diseases. J Biol Chem 295(34):12279\u201312289","journal-title":"J Biol Chem"},{"issue":"8","key":"1215_CR15","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/nrc2676","volume":"9","author":"DB Shackelford","year":"2009","unstructured":"Shackelford DB, Shaw RJ (2009) The LKB1-AMPK pathway: metabolism and growth control in tumour suppression. Nat Rev Cancer 9(8):563\u2013575","journal-title":"Nat Rev Cancer"},{"issue":"6663","key":"1215_CR16","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/34432","volume":"391","author":"A Hemminki","year":"1998","unstructured":"Hemminki A, Markie D, Tomlinson I, Avizienyte E, Roth S, Loukola A et al (1998) A serine\/threonine kinase gene defective in Peutz\u2013Jeghers syndrome. Nature 391(6663):184\u2013187","journal-title":"Nature"},{"issue":"1","key":"1215_CR17","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1146\/annurev.biochem.75.103004.142702","volume":"75","author":"DR Alessi","year":"2006","unstructured":"Alessi DR, Sakamoto K, Bayascas JR (2006) LKB1-dependent signaling pathways. Annu Rev Biochem 75(1):137\u2013163","journal-title":"Annu Rev Biochem"},{"key":"1215_CR18","first-page":"3","volume-title":"Regulation of Autophagy by AMPK","author":"Y Ren","year":"2017","unstructured":"Ren Y, Xie H, Shen H-M (2017) Regulation of Autophagy by AMPK. CRC, Autophagy and Signaling, pp 3\u201324"},{"issue":"5960","key":"1215_CR19","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1126\/science.1178377","volume":"326","author":"E Zeqiraj","year":"2009","unstructured":"Zeqiraj E, Filippi BM, Deak M, Alessi DR, van Aalten DM (2009) Structure of the LKB1-STRAD-MO25 complex reveals an allosteric mechanism of kinase activation. Science 326(5960):1707\u20131711","journal-title":"Science"},{"issue":"4","key":"1215_CR20","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/1475-4924-2-28","volume":"2","author":"SA Hawley","year":"2003","unstructured":"Hawley SA, Boudeau J, Reid JL, Mustard KJ, Udd L, M\u00e4kel\u00e4 TP et al (2003) Complexes between the LKB1 tumor suppressor, STRAD\u03b1\/\u03b2 and MO25\u03b1\/\u03b2 are upstream kinases in the AMP-activated protein kinase cascade. J Biol 2(4):28","journal-title":"J Biol"},{"issue":"32","key":"1215_CR21","doi-asserted-by":"publisher","first-page":"29060","DOI":"10.1074\/jbc.M503824200","volume":"280","author":"RL Hurley","year":"2005","unstructured":"Hurley RL, Anderson KA, Franzone JM, Kemp BE, Means AR, Witters LA (2005) The Ca2+\/calmodulin-dependent protein kinase kinases are AMP-activated protein kinase kinases. J Biol Chem 280(32):29060\u201329066","journal-title":"J Biol Chem"},{"issue":"1","key":"1215_CR22","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.cmet.2005.06.005","volume":"2","author":"A Woods","year":"2005","unstructured":"Woods A, Dickerson K, Heath R, Hong S-P, Momcilovic M, Johnstone SR et al (2005) Ca2+\/calmodulin-dependent protein kinase kinase-\u03b2 acts upstream of AMP-activated protein kinase in mammalian cells. Cell Metabol 2(1):21\u201333","journal-title":"Cell Metabol"},{"issue":"1","key":"1215_CR23","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1042\/BST20130244","volume":"42","author":"GJ Gowans","year":"2014","unstructured":"Gowans GJ, Hardie DG (2014) AMPK: a cellular energy sensor primarily regulated by AMP. Biochem Soc Trans 42(1):71\u201375","journal-title":"Biochem Soc Trans"},{"issue":"6","key":"1215_CR24","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.molcel.2017.05.032","volume":"66","author":"D Garcia","year":"2017","unstructured":"Garcia D, Shaw RJ (2017) AMPK: mechanisms of cellular energy sensing and restoration of metabolic balance. Mol Cell 66(6):789\u2013800","journal-title":"Mol Cell"},{"key":"1215_CR25","doi-asserted-by":"publisher","first-page":"190","DOI":"10.3389\/fpls.2014.00190","volume":"5","author":"P Crozet","year":"2014","unstructured":"Crozet P, Margalha L, Confraria A, Rodrigues A, Martinho C, Adamo M et al (2014) Mechanisms of regulation of SNF1\/AMPK\/SnRK1 protein kinases. Front Plant Sci 5:190","journal-title":"Front Plant Sci"},{"issue":"1","key":"1215_CR26","doi-asserted-by":"publisher","first-page":"10122","DOI":"10.1038\/s41598-018-28074-w","volume":"8","author":"H Endo","year":"2018","unstructured":"Endo H, Owada S, Inagaki Y, Shida Y, Tatemichi M (2018) Glucose starvation induces LKB1-AMPK-mediated MMP-9 expression in cancer cells. Sci Rep 8(1):10122","journal-title":"Sci Rep"},{"issue":"1","key":"1215_CR27","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/1741-7007-11-36","volume":"11","author":"DG Hardie","year":"2013","unstructured":"Hardie DG, Alessi DR (2013) LKB1 and AMPK and the cancer-metabolism link-ten years after. BMC Biol 11(1):36","journal-title":"BMC Biol"},{"issue":"7665","key":"1215_CR28","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/nature23275","volume":"548","author":"C-S Zhang","year":"2017","unstructured":"Zhang C-S, Hawley SA, Zong Y, Li M, Wang Z, Gray A et al (2017) Fructose-1, 6-bisphosphate and aldolase mediate glucose sensing by AMPK. Nature 548(7665):112\u2013116","journal-title":"Nature"},{"issue":"3","key":"1215_CR29","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.tcb.2015.10.013","volume":"26","author":"DG Hardie","year":"2016","unstructured":"Hardie DG, Schaffer BE, Brunet A (2016) AMPK: an energy-sensing pathway with multiple inputs and outputs. Trends Cell Biol 26(3):190\u2013201","journal-title":"Trends Cell Biol"},{"issue":"7","key":"1215_CR30","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1248\/bpb.b17-00724","volume":"41","author":"Q Wang","year":"2018","unstructured":"Wang Q, Liu S, Zhai A, Zhang B, Tian G (2018) AMPK-mediated regulation of lipid metabolism by phosphorylation. Biol Pharm Bull 41(7):985\u2013993","journal-title":"Biol Pharm Bull"},{"issue":"4","key":"1215_CR31","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/s41580-022-00547-x","volume":"24","author":"GR Steinberg","year":"2023","unstructured":"Steinberg GR, Hardie DG (2023) New insights into activation and function of the AMPK. Nat Rev Mol Cell Biol 24(4):255\u2013272","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"6","key":"1215_CR32","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1042\/bst0301064","volume":"30","author":"DG Hardie","year":"2002","unstructured":"Hardie DG, Pan DA (2002) Regulation of fatty acid synthesis and oxidation by the AMP-activated protein kinase. Biochem Soc Trans 30(6):1064\u20131070","journal-title":"Biochem Soc Trans"},{"issue":"7400","key":"1215_CR33","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/nature11066","volume":"485","author":"S-M Jeon","year":"2012","unstructured":"Jeon S-M, Chandel NS, Hay N (2012) AMPK regulates NADPH homeostasis to promote tumour cell survival during energy stress. Nature 485(7400):661\u2013665","journal-title":"Nature"},{"issue":"6016","key":"1215_CR34","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1126\/science.1196371","volume":"331","author":"DF Egan","year":"2011","unstructured":"Egan DF, Shackelford DB, Mihaylova MM, Gelino S, Kohnz RA, Mair W et al (2011) Phosphorylation of ULK1 (hATG1) by AMP-activated protein kinase connects energy sensing to mitophagy. Science 331(6016):456\u2013461","journal-title":"Science"},{"issue":"1","key":"1215_CR35","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ccr.2007.05.008","volume":"12","author":"DA Guertin","year":"2007","unstructured":"Guertin DA, Sabatini DM (2007) Defining the role of mTOR in cancer. Cancer Cell 12(1):9\u201322","journal-title":"Cancer Cell"},{"issue":"1","key":"1215_CR36","doi-asserted-by":"publisher","first-page":"32","DOI":"10.2174\/1389450114666140106095811","volume":"15","author":"R-X Zhao","year":"2014","unstructured":"Zhao R-X, Xu Z-X (2014) Targeting the LKB1 tumor suppressor. Curr Drug Targets 15(1):32\u201352","journal-title":"Curr Drug Targets"},{"issue":"5","key":"1215_CR37","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.3390\/ijms19051474","volume":"19","author":"A Polchi","year":"2018","unstructured":"Polchi A, Magini A, Meo DD, Tancini B, Emiliani C (2018) mTOR signaling and neural stem cells: the tuberous sclerosis complex model. Int J Mol Sci 19(5):1474","journal-title":"Int J Mol Sci"},{"issue":"2","key":"1215_CR38","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.molcel.2008.03.003","volume":"30","author":"DM Gwinn","year":"2008","unstructured":"Gwinn DM, Shackelford DB, Egan DF, Mihaylova MM, Mery A, Vasquez DS et al (2008) AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol Cell 30(2):214\u2013226","journal-title":"Mol Cell"},{"issue":"9","key":"1215_CR39","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1016\/j.bbadis.2014.07.002","volume":"1842","author":"H Li","year":"2014","unstructured":"Li H, Min Q, Ouyang C, Lee J, He C, Zou MH et al (2014) AMPK activation prevents excess nutrient-induced hepatic lipid accumulation by inhibiting mTORC1 signaling and endoplasmic reticulum stress response. Biochim Biophys Acta 1842(9):1844\u20131854","journal-title":"Biochim Biophys Acta"},{"issue":"6","key":"1215_CR40","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1016\/j.immuni.2024.04.024","volume":"57","author":"J Sun","year":"2024","unstructured":"Sun J, Zhang Y, Zhang Q, Hu L, Zhao L, Wang H et al (2024) Metabolic regulator LKB1 controls adipose tissue ILC2 PD-1 expression and mitochondrial homeostasis to prevent insulin resistance. Immunity 57(6):1289\u2013305e9","journal-title":"Immunity"},{"key":"1215_CR41","doi-asserted-by":"publisher","first-page":"154423","DOI":"10.1016\/j.phymed.2022.154423","volume":"106","author":"Z Yong","year":"2022","unstructured":"Yong Z, ruiqi W, Yanan Y, ning M, Zhi Z, Yinfeng T et al (2022) Laurolitsine ameliorates type 2 diabetes by regulating the hepatic LKB1-AMPK pathway and gut microbiota. Phytomedicine 106:154423","journal-title":"Phytomedicine"},{"issue":"9","key":"1215_CR42","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.2174\/0109298673289342240213040144","volume":"32","author":"P Shivaprakash","year":"2025","unstructured":"Shivaprakash P, Beeraka NM, Madhunapantula SRV, Nikolenko VN, Basalingappa KM (2025) Metformin Effects on SHIP2, AMPKs and Gut Microbiota: Recent Updates on Pharmacology. Curr Med Chem 32(9):1732\u20131754","journal-title":"Curr Med Chem"},{"issue":"12","key":"1215_CR43","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.3390\/ph16121714","volume":"16","author":"LM Isop","year":"2023","unstructured":"Isop LM, Neculau AE, Necula RD, Kakucs C, Moga MA, Dima L (2023) Metformin: The Winding Path from Understanding Its Molecular Mechanisms to Proving Therapeutic Benefits in Neurodegenerative Disorders. Pharmaceuticals (Basel) 16(12):1714","journal-title":"Pharmaceuticals (Basel)"},{"issue":"2","key":"1215_CR44","doi-asserted-by":"publisher","first-page":"177","DOI":"10.7570\/jomes23048","volume":"33","author":"SY Huang","year":"2024","unstructured":"Huang SY, Chung MT, Kung CW, Chen SY, Chen YW, Pan T et al (2024) Alpha-Lipoic Acid Induces Adipose Tissue Browning through AMP-Activated Protein Kinase Signaling in Vivo and in Vitro. J Obes Metab Syndr 33(2):177\u2013188","journal-title":"J Obes Metab Syndr"},{"key":"1215_CR45","doi-asserted-by":"publisher","first-page":"155313","DOI":"10.1016\/j.phymed.2023.155313","volume":"128","author":"G Gao","year":"2024","unstructured":"Gao G, Zhao J, Ding J, Liu S, Shen Y, Liu C et al (2024) Alisol B regulates AMPK\/mTOR\/SREBPs via directly targeting VDAC1 to alleviate hyperlipidemia. Phytomedicine 128:155313","journal-title":"Phytomedicine"},{"key":"1215_CR46","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.ebiom.2018.01.008","volume":"28","author":"N Boudaba","year":"2018","unstructured":"Boudaba N, Marion A, Huet C, Pierre R, Viollet B, Foretz M (2018) AMPK Re-Activation Suppresses Hepatic Steatosis but its Downregulation Does Not Promote Fatty Liver Development. EBioMedicine 28:194\u2013209","journal-title":"EBioMedicine"},{"issue":"5","key":"1215_CR47","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/j.jhep.2013.12.012","volume":"60","author":"D Casta\u00f1o","year":"2014","unstructured":"Casta\u00f1o D, Larequi E, Belza I, Astudillo AM, Mart\u00ednez-Ans\u00f3 E, Balsinde J et al (2014) Cardiotrophin-1 eliminates hepatic steatosis in obese mice by mechanisms involving AMPK activation. J Hepatol 60(5):1017\u20131025","journal-title":"J Hepatol"},{"issue":"15","key":"1215_CR48","doi-asserted-by":"publisher","first-page":"7904","DOI":"10.3390\/ijms22157904","volume":"22","author":"JH Heo","year":"2021","unstructured":"Heo JH, Lee SR, Jo SL, Ko JW, Kwon HJ, Hong EJ (2021) Hepatic LKB1 Reduces the Progression of Non-Alcoholic Fatty Liver Disease via Genomic Androgen Receptor Signaling. Int J Mol Sci 22(15):7904","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1215_CR49","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s10020-019-0085-2","volume":"25","author":"JK Long","year":"2019","unstructured":"Long JK, Dai W, Zheng YW, Zhao SP (2019) miR-122 promotes hepatic lipogenesis via inhibiting the LKB1\/AMPK pathway by targeting Sirt1 in non-alcoholic fatty liver disease. Mol Med 25(1):26","journal-title":"Mol Med"},{"key":"1215_CR50","doi-asserted-by":"publisher","first-page":"156266","DOI":"10.1016\/j.metabol.2025.156266","volume":"169","author":"YH Lee","year":"2025","unstructured":"Lee YH, Lee J, Jeong J, Park K, Baik B, Kwon Y et al (2025) Hepatic miR-93 promotes the pathogenesis of metabolic dysfunction-associated steatotic liver disease by suppressing SIRT1. Metabolism 169:156266","journal-title":"Metabolism"},{"issue":"4","key":"1215_CR51","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.jhep.2012.11.042","volume":"58","author":"Z Derdak","year":"2013","unstructured":"Derdak Z, Villegas KA, Harb R, Wu AM, Sousa A, Wands JR (2013) Inhibition of p53 attenuates steatosis and liver injury in a mouse model of non-alcoholic fatty liver disease. J Hepatol 58(4):785\u2013791","journal-title":"J Hepatol"},{"issue":"1","key":"1215_CR52","doi-asserted-by":"publisher","first-page":"5405","DOI":"10.1038\/s41467-023-41145-5","volume":"14","author":"B Qiu","year":"2023","unstructured":"Qiu B, Lawan A, Xirouchaki CE, Yi JS, Robert M, Zhang L et al (2023) MKP1 promotes nonalcoholic steatohepatitis by suppressing AMPK activity through LKB1 nuclear retention. Nat Commun 14(1):5405","journal-title":"Nat Commun"},{"issue":"8","key":"1215_CR53","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.2337\/db17-0490","volume":"67","author":"B Romier","year":"2018","unstructured":"Romier B, Ivaldi C, Sartelet H, Heinz A, Schmelzer CEH, Garnotel R et al (2018) Production of Elastin-Derived Peptides Contributes to the Development of Nonalcoholic Steatohepatitis. Diabetes 67(8):1604\u20131615","journal-title":"Diabetes"},{"issue":"11","key":"1215_CR54","doi-asserted-by":"publisher","first-page":"e157948","DOI":"10.1172\/jci.insight.157948","volume":"8","author":"HJ van der Zande","year":"2023","unstructured":"van der Zande HJ, Brombacher EC, Lambooij JM, Pelgrom LR, Zawistowska-Deniziak A, Patente TA et al (2023) Dendritic cell-intrinsic LKB1-AMPK\/SIK signaling controls metabolic homeostasis by limiting the hepatic Th17 response during obesity. JCI Insight 8(11):e157948","journal-title":"JCI Insight"},{"issue":"8","key":"1215_CR55","doi-asserted-by":"publisher","first-page":"104806","DOI":"10.1016\/j.isci.2022.104806","volume":"25","author":"AA Widjaja","year":"2022","unstructured":"Widjaja AA, Viswanathan S, Wei Ting JG, Tan J, Shekeran SG, Carling D et al (2022) IL11 stimulates ERK\/P90RSK to inhibit LKB1\/AMPK and activate mTOR initiating a mesenchymal program in stromal, epithelial, and cancer cells. iScience 25(8):104806","journal-title":"iScience"},{"issue":"3","key":"1215_CR56","doi-asserted-by":"publisher","first-page":"111498","DOI":"10.1016\/j.celrep.2022.111498","volume":"41","author":"L Xie","year":"2022","unstructured":"Xie L, Yuan Y, Xu S, Lu S, Gu J, Wang Y et al (2022) Downregulation of hepatic ceruloplasmin ameliorates NAFLD via SCO1-AMPK-LKB1 complex. Cell Rep 41(3):111498","journal-title":"Cell Rep"},{"key":"1215_CR57","doi-asserted-by":"publisher","first-page":"1099624","DOI":"10.3389\/fonc.2023.1099624","volume":"13","author":"SS Meng","year":"2023","unstructured":"Meng SS, Gu HW, Zhang T, Li YS, Tang HB (2023) Gradual deterioration of fatty liver disease to liver cancer via inhibition of AMPK signaling pathways involved in energy-dependent disorders, cellular aging, and chronic inflammation. Front Oncol 13:1099624","journal-title":"Front Oncol"},{"issue":"4","key":"1215_CR58","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.cmet.2013.09.005","volume":"18","author":"YL Zhang","year":"2013","unstructured":"Zhang YL, Guo H, Zhang CS, Lin SY, Yin Z, Peng Y et al (2013) AMP as a low-energy charge signal autonomously initiates assembly of AXIN-AMPK-LKB1 complex for AMPK activation. Cell Metab 18(4):546\u2013555","journal-title":"Cell Metab"},{"issue":"50","key":"1215_CR59","doi-asserted-by":"publisher","first-page":"13929","DOI":"10.1021\/acs.jafc.9b05632","volume":"67","author":"L Gu","year":"2019","unstructured":"Gu L, Cai N, Lyu Y, Yao L, Wang F, Xu H et al (2019) \u03b3-Mangostin Ameliorates Free Fatty Acid-Induced Lipid Accumulation via the SIRT1\/LKB1\/AMPK Pathway in HepG2 and L02 Cells. J Agric Food Chem 67(50):13929\u201313938","journal-title":"J Agric Food Chem"},{"issue":"3","key":"1215_CR60","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1002\/ptr.6902","volume":"35","author":"D Li","year":"2021","unstructured":"Li D, Cui Y, Wang X, Liu F, Li X (2021) Apple polyphenol extract alleviates lipid accumulation in free-fatty-acid-exposed HepG2 cells via activating autophagy mediated by SIRT1\/AMPK signaling. Phytother Res 35(3):1416\u20131431","journal-title":"Phytother Res"},{"issue":"18","key":"1215_CR61","doi-asserted-by":"publisher","first-page":"5579","DOI":"10.1021\/acs.jafc.2c01461","volume":"70","author":"Y Yin","year":"2022","unstructured":"Yin Y, Li D, Liu F, Wang X, Cui Y, Li S et al (2022) The Ameliorating Effects of Apple Polyphenol Extract on High-Fat-Diet-Induced Hepatic Steatosis Are SIRT1-Dependent: Evidence from Hepatic-Specific SIRT1 Heterozygous Mutant C57BL\/6 Mice. J Agric Food Chem 70(18):5579\u20135594","journal-title":"J Agric Food Chem"},{"key":"1215_CR62","doi-asserted-by":"publisher","first-page":"173244","DOI":"10.1016\/j.ejphar.2020.173244","volume":"882","author":"A Sharma","year":"2020","unstructured":"Sharma A, Anand SK, Singh N, Dwivedi UN, Kakkar P (2020) Berbamine induced AMPK activation regulates mTOR\/SREBP-1c axis and Nrf2\/ARE pathway to allay lipid accumulation and oxidative stress in steatotic HepG2 cells. Eur J Pharmacol 882:173244","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"1215_CR63","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1039\/D0FO02501A","volume":"12","author":"A Sharma","year":"2021","unstructured":"Sharma A, Anand SK, Singh N, Dwarkanath A, Dwivedi UN, Kakkar P (2021) Berbamine induced activation of the SIRT1\/LKB1\/AMPK signaling axis attenuates the development of hepatic steatosis in high-fat diet-induced NAFLD rats. Food Funct 12(2):892\u2013909","journal-title":"Food Funct"},{"key":"1215_CR64","doi-asserted-by":"publisher","first-page":"36209","DOI":"10.1038\/srep36209","volume":"6","author":"L Jia","year":"2016","unstructured":"Jia L, Li W, Li J, Li Y, Song H, Luan Y et al (2016) Lycium barbarum polysaccharide attenuates high-fat diet-induced hepatic steatosis by up-regulating SIRT1 expression and deacetylase activity. Sci Rep 6:36209","journal-title":"Sci Rep"},{"issue":"11","key":"1215_CR65","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1016\/j.jnutbio.2014.06.001","volume":"25","author":"Y Yang","year":"2014","unstructured":"Yang Y, Li W, Liu Y, Sun Y, Li Y, Yao Q et al (2014) Alpha-lipoic acid improves high-fat diet-induced hepatic steatosis by modulating the transcription factors SREBP-1, FoxO1 and Nrf2 via the SIRT1\/LKB1\/AMPK pathway. J Nutr Biochem 25(11):1207\u20131217","journal-title":"J Nutr Biochem"},{"issue":"6","key":"1215_CR66","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1080\/15548627.2025.2466145","volume":"21","author":"M Chen","year":"2025","unstructured":"Chen M, Liu G, Fang Z, Gao W, Song Y, Lei L et al (2025) Buddleoside alleviates nonalcoholic steatohepatitis by targeting the AMPK-TFEB signaling pathway. Autophagy 21(6):1316\u20131334","journal-title":"Autophagy"},{"key":"1215_CR67","doi-asserted-by":"publisher","first-page":"114921","DOI":"10.1016\/j.intimp.2025.114921","volume":"159","author":"TT Fu","year":"2025","unstructured":"Fu TT, Fu RQ, Liu HQ, Fu HL, Su R, Wu JJ et al (2025) Identification of 1,2,3,4,6-O-Pentagalloylglucose as a novel ASNS inhibitor for MASLD amelioration in mice by increasing l-aspartate levels alongside LKB1\/AMPK metabolic axis activation. Int Immunopharmacol 159:114921","journal-title":"Int Immunopharmacol"},{"issue":"3","key":"1215_CR68","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1007\/s11418-018-1199-5","volume":"72","author":"Q Chen","year":"2018","unstructured":"Chen Q, Liu M, Yu H, Li J, Wang S, Zhang Y et al (2018) Scutellaria baicalensis regulates FFA metabolism to ameliorate NAFLD through the AMPK-mediated SREBP signaling pathway. J Nat Med 72(3):655\u2013666","journal-title":"J Nat Med"},{"issue":"2","key":"1215_CR69","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s11745-016-4222-1","volume":"52","author":"Y Liu","year":"2017","unstructured":"Liu Y, Shi D, Tian Y, Liu Y, Zhan Q, Xu J et al (2017) Eicosapentaenoic Acid-Enriched Phosphatidylcholine Attenuated Hepatic Steatosis Through Regulation of Cholesterol Metabolism in Rats with Nonalcoholic Fatty Liver Disease. Lipids 52(2):119\u2013127","journal-title":"Lipids"},{"issue":"6","key":"1215_CR70","doi-asserted-by":"publisher","first-page":"842","DOI":"10.3390\/nu16060842","volume":"16","author":"Y Shi","year":"2024","unstructured":"Shi Y, Chen J, Qu D, Sun Q, Yu Y, Zhang H et al (2024) Ginsenoside Rg(5) Activates the LKB1\/AMPK\/mTOR Signaling Pathway and Modifies the Gut Microbiota to Alleviate Nonalcoholic Fatty Liver Disease Induced by a High-Fat Diet. Nutrients 16(6):842","journal-title":"Nutrients"},{"issue":"9","key":"1215_CR71","doi-asserted-by":"publisher","first-page":"e0331303","DOI":"10.1371\/journal.pone.0331303","volume":"20","author":"J Zhu","year":"2025","unstructured":"Zhu J, Chen Y, Han Y, Li J (2025) Mechanism of Huanglian Wendan Decoction in ameliorating non-alcoholic fatty liver disease via modulating gut microbiota-mediated metabolic reprogramming and activating the LKB1\/AMPK pathway. PLoS ONE 20(9):e0331303","journal-title":"PLoS ONE"},{"issue":"9","key":"1215_CR72","doi-asserted-by":"publisher","first-page":"105476","DOI":"10.1016\/j.psj.2025.105476","volume":"104","author":"S Miao","year":"2025","unstructured":"Miao S, Xu M, Liu F, Dong X, Zou X, Zeng T et al (2025) Sodium butyrate attenuates lipid metabolism disorder via improving mitochondrial function and activating autophagy in LMH cells. Poult Sci 104(9):105476","journal-title":"Poult Sci"},{"issue":"10","key":"1215_CR73","doi-asserted-by":"publisher","first-page":"R1215","DOI":"10.1152\/ajpregu.00260.2015","volume":"309","author":"V Sid","year":"2015","unstructured":"Sid V, Wu N, Sarna LK, Siow YL, House JD (2015) Folic acid supplementation during high-fat diet feeding restores AMPK activation via an AMP-LKB1-dependent mechanism. Am J Physiol Regul Integr Comp Physiol 309(10):R1215\u2013R1225","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"4","key":"1215_CR74","doi-asserted-by":"publisher","first-page":"309","DOI":"10.4162\/nrp.2020.14.4.309","volume":"14","author":"H Kim","year":"2020","unstructured":"Kim H, Min H (2020) Folic acid supplementation prevents high fructose-induced non-alcoholic fatty liver disease by activating the AMPK and LKB1 signaling pathways. Nutr Res Pract 14(4):309\u2013321","journal-title":"Nutr Res Pract"},{"key":"1215_CR75","doi-asserted-by":"publisher","first-page":"108794","DOI":"10.1016\/j.cbi.2019.108794","volume":"311","author":"X Han","year":"2019","unstructured":"Han X, Cui ZY, Song J, Piao HQ, Lian LH, Hou LS et al (2019) Acanthoic acid modulates lipogenesis in nonalcoholic fatty liver disease via FXR\/LXRs-dependent manner. Chem Biol Interact 311:108794","journal-title":"Chem Biol Interact"},{"issue":"11","key":"1215_CR76","doi-asserted-by":"publisher","first-page":"e0141227","DOI":"10.1371\/journal.pone.0141227","volume":"10","author":"AB Santamarina","year":"2015","unstructured":"Santamarina AB, Oliveira JL, Silva FP, Carnier J, Mennitti LV, Santana AA et al (2015) Green Tea Extract Rich in Epigallocatechin-3-Gallate Prevents Fatty Liver by AMPK Activation via LKB1 in Mice Fed a High-Fat Diet. PLoS ONE 10(11):e0141227","journal-title":"PLoS ONE"},{"issue":"8","key":"1215_CR77","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.3390\/nu10081024","volume":"10","author":"YC Li","year":"2018","unstructured":"Li YC, Qiao JY, Wang BY, Bai M, Shen JD, Cheng YX (2018) Paeoniflorin Ameliorates Fructose-Induced Insulin Resistance and Hepatic Steatosis by Activating LKB1\/AMPK and AKT Pathways. Nutrients 10(8):1024","journal-title":"Nutrients"},{"issue":"2","key":"1215_CR78","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1007\/s12020-012-9761-5","volume":"43","author":"Y Li","year":"2013","unstructured":"Li Y, Hai J, Li L, Chen X, Peng H, Cao M et al (2013) Administration of ghrelin improves inflammation, oxidative stress, and apoptosis during and after non-alcoholic fatty liver disease development. Endocrine 43(2):376\u2013386","journal-title":"Endocrine"},{"issue":"10","key":"1215_CR79","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1111\/bph.15008","volume":"178","author":"X Hua","year":"2021","unstructured":"Hua X, Sun DY, Zhang WJ, Fu JT, Tong J, Sun SJ et al (2021) P7C3-A20 alleviates fatty liver by shaping gut microbiota and inducing FGF21\/FGF1, via the AMP-activated protein kinase\/CREB regulated transcription coactivator 2 pathway. Br J Pharmacol 178(10):2111\u20132130","journal-title":"Br J Pharmacol"},{"key":"1215_CR80","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.ejphar.2016.06.040","volume":"788","author":"EJ Park","year":"2016","unstructured":"Park EJ, Kim YM, Kim HJ, Jang SY, Oh MH, Lee DH et al (2016) (S)YS-51, a novel isoquinoline alkaloid, attenuates obesity-associated non-alcoholic fatty liver disease in mice by suppressing lipogenesis, inflammation and coagulation. Eur J Pharmacol 788:200\u2013209","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"1215_CR81","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s13770-024-00684-8","volume":"22","author":"N Maharajan","year":"2025","unstructured":"Maharajan N, Kim KH, Vijayakumar KA, Cho GW (2025) Unlocking Therapeutic Potential: Camphorquinone\u2019s Role in Alleviating Non-Alcoholic Fatty Liver Disease via SIRT1\/LKB1\/AMPK Pathway Activation. Tissue Eng Regen Med 22(1):129\u2013144","journal-title":"Tissue Eng Regen Med"},{"issue":"2","key":"1215_CR82","doi-asserted-by":"publisher","first-page":"100740","DOI":"10.1016\/j.jlr.2024.100740","volume":"66","author":"W Qin","year":"2025","unstructured":"Qin W, Ding Y, Zhang W, Sun L, Weng J, Zheng X et al (2025) Small molecule-driven LKB1 deacetylation is responsible for the inhibition of hepatic lipid response in NAFLD. J Lipid Res 66(2):100740","journal-title":"J Lipid Res"},{"issue":"16","key":"1215_CR83","doi-asserted-by":"publisher","first-page":"2877","DOI":"10.1111\/bph.14713","volume":"176","author":"Y Rao","year":"2019","unstructured":"Rao Y, Lu YT, Li C, Song QQ, Xu YH, Xu Z et al (2019) Bouchardatine analogue alleviates non-alcoholic hepatic fatty liver disease\/non-alcoholic steatohepatitis in high-fat fed mice by inhibiting ATP synthase activity. Br J Pharmacol 176(16):2877\u20132893","journal-title":"Br J Pharmacol"},{"issue":"11","key":"1215_CR84","doi-asserted-by":"publisher","first-page":"4050","DOI":"10.1111\/1750-3841.15482","volume":"85","author":"H Gai","year":"2020","unstructured":"Gai H, Zhou F, Zhang Y, Ai J, Zhan J, You Y et al (2020) Coniferaldehyde ameliorates the lipid and glucose metabolism in palmitic acid-induced HepG2 cells via the LKB1\/AMPK signaling pathway. J Food Sci 85(11):4050\u20134060","journal-title":"J Food Sci"},{"key":"1215_CR85","doi-asserted-by":"publisher","first-page":"537","DOI":"10.3389\/fphar.2018.00537","volume":"9","author":"MJ Kang","year":"2018","unstructured":"Kang MJ, Kwon EB, Ryu HW, Lee S, Lee JW, Kim DY et al (2018) Polyacetylene From Dendropanax morbifera Alleviates Diet-Induced Obesity and Hepatic Steatosis by Activating AMPK Signaling Pathway. Front Pharmacol 9:537","journal-title":"Front Pharmacol"},{"key":"1215_CR86","doi-asserted-by":"publisher","first-page":"642920","DOI":"10.1155\/2013\/642920","volume":"2013","author":"J Xiao","year":"2013","unstructured":"Xiao J, Guo R, Fung ML, Liong EC, Chang RC, Ching YP et al (2013) Garlic-Derived S-Allylmercaptocysteine Ameliorates Nonalcoholic Fatty Liver Disease in a Rat Model through Inhibition of Apoptosis and Enhancing Autophagy. Evid Based Complement Alternat Med 2013:642920","journal-title":"Evid Based Complement Alternat Med"},{"key":"1215_CR87","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.nano.2019.01.013","volume":"17","author":"S Dogra","year":"2019","unstructured":"Dogra S, Kar AK, Girdhar K, Daniel PV, Chatterjee S, Choubey A et al (2019) Zinc oxide nanoparticles attenuate hepatic steatosis development in high-fat-diet fed mice through activated AMPK signaling axis. Nanomedicine 17:210\u2013222","journal-title":"Nanomedicine"},{"issue":"4","key":"1215_CR88","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1093\/jpp\/rgaf005","volume":"77","author":"Y Lei","year":"2025","unstructured":"Lei Y, Wang L, Song L, Han J, Ma H, Luo H et al (2025) Tiaogan Jiejiu Tongluo formula alleviates hepatic steatosis in NAFLD mice by regulating AMPK signaling pathway. J Pharm Pharmacol 77(4):492\u2013500","journal-title":"J Pharm Pharmacol"},{"issue":"44","key":"1215_CR89","doi-asserted-by":"publisher","first-page":"12208","DOI":"10.1021\/acs.jafc.9b05495","volume":"67","author":"D Li","year":"2019","unstructured":"Li D, Liu F, Wang X, Li X (2019) Apple Polyphenol Extract Alleviates High-Fat-Diet-Induced Hepatic Steatosis in Male C57BL\/6 Mice by Targeting LKB1\/AMPK Pathway. J Agric Food Chem 67(44):12208\u201312218","journal-title":"J Agric Food Chem"},{"issue":"29","key":"1215_CR90","doi-asserted-by":"publisher","first-page":"8257","DOI":"10.1021\/acs.jafc.1c02596","volume":"69","author":"Y Liang","year":"2021","unstructured":"Liang Y, Zhang Z, Tu J, Wang Z, Gao X, Deng K et al (2021) \u03b3-Linolenic Acid Prevents Lipid Metabolism Disorder in Palmitic Acid-Treated Alpha Mouse Liver-12 Cells by Balancing Autophagy and Apoptosis via the LKB1-AMPK-mTOR Pathway. J Agric Food Chem 69(29):8257\u20138267","journal-title":"J Agric Food Chem"},{"issue":"7","key":"1215_CR91","doi-asserted-by":"publisher","first-page":"6285","DOI":"10.3390\/ijms24076285","volume":"24","author":"Y Liu","year":"2023","unstructured":"Liu Y, Li D, Wang S, Peng Z, Tan Q, He Q et al (2023) 6-Gingerol Ameliorates Hepatic Steatosis, Inflammation and Oxidative Stress in High-Fat Diet-Fed Mice through Activating LKB1\/AMPK Signaling. Int J Mol Sci 24(7):6285","journal-title":"Int J Mol Sci"},{"issue":"2","key":"1215_CR92","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s13205-024-04204-2","volume":"15","author":"X Luo","year":"2025","unstructured":"Luo X, Fang Y, Wang W, Tong M, Qin B, Cao J et al (2025) Yinchen lipid-lowering tea attenuates lipid deposition in a fatty liver model by regulating mitochondrial dysfunction through activation of AdipoR1\/AMPK\/SIRT1 signaling. 3 Biotech 15(2):39","journal-title":"3 Biotech"},{"issue":"7","key":"1215_CR93","doi-asserted-by":"publisher","first-page":"e81","DOI":"10.1038\/nutd.2013.22","volume":"3","author":"J Xiao","year":"2013","unstructured":"Xiao J, Liong EC, Ching YP, Chang RC, Fung ML, Xu AM et al (2013) Lycium barbarum polysaccharides protect rat liver from non-alcoholic steatohepatitis-induced injury. Nutr Diabetes 3(7):e81","journal-title":"Nutr Diabetes"},{"issue":"3","key":"1215_CR94","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1039\/D1FO03026D","volume":"13","author":"J Zhang","year":"2022","unstructured":"Zhang J, Ma X, Fan D (2022) Ginsenoside CK ameliorates hepatic lipid accumulation via activating the LKB1\/AMPK pathway in vitro and in vivo. Food Funct 13(3):1153\u20131167","journal-title":"Food Funct"},{"issue":"3","key":"1215_CR95","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.jcmgh.2021.05.006","volume":"12","author":"ZH Zhao","year":"2021","unstructured":"Zhao ZH, Wang ZX, Zhou D, Han Y, Ma F, Hu Z et al (2021) Sodium Butyrate Supplementation Inhibits Hepatic Steatosis by Stimulating Liver Kinase B1 and Insulin-Induced Gene. Cell Mol Gastroenterol Hepatol 12(3):857\u2013871","journal-title":"Cell Mol Gastroenterol Hepatol"}],"container-title":["Journal of Physiology and Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13105-026-01215-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13105-026-01215-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13105-026-01215-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T11:05:16Z","timestamp":1786705516000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13105-026-01215-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,14]]},"references-count":95,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["1215"],"URL":"https:\/\/doi.org\/10.1007\/s13105-026-01215-w","relation":{},"ISSN":["1138-7548","1877-8755"],"issn-type":[{"value":"1138-7548","type":"print"},{"value":"1877-8755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,14]]},"assertion":[{"value":"20 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Clinical trial number","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"During the preparation of this work the authors used ChatGPT and DeepSeek to check for grammar mistakes and to improve the readability of the work. After using this tool\/service, the authors reviewed and edited the content as needed.","order":5,"name":"Ethics","label":"Use of large language models AI, and machine learning tools","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"80"}}